Shopping Cart
- Remove All
Your shopping cart is currently empty
NLG802
🥰Excellent
Catalog No. T39476Cas No. 2071683-99-1
NLG802 is a prodrug of indoximod, serving as an orally active inhibitor of indoleamine 2,3-dioxygenase (IDO).
NLG802
🥰Excellent
Purity: 99.08%
Catalog No. T39476Cas No. 2071683-99-1
NLG802 is a prodrug of indoximod, serving as an orally active inhibitor of indoleamine 2,3-dioxygenase (IDO).
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | 41 € | In Stock | |
| 5 mg | 93 € | In Stock | |
| 10 mg | 154 € | In Stock | |
| 25 mg | 282 € | In Stock | |
| 50 mg | 392 € | In Stock |
Bulk & Custom
Add to Cart
Questions
View MoreInhibitors Related to "NLG802"
Indoximod
Cited
NLG-8189, Indoximod (NLG-8189）, 1-Methyl-D-tryptophan
T6543110117-83-4
Indoximod (NLG-8189) is a methylated tryptophan with immune checkpoint inhibitory activity. Indoximod inhibits the enzyme indoleamine 2, 3-dioxygenase (IDO), which degrades the essential amino acid tryptophan, and may increase or maintain tryptophan levels important to T cell function. Tryptophan depletion is associated with immunosuppression involving T cell arrest and anergy.
- 38 €
Size
QTY
CitedEpacadostat
Cited
INCB 024360, IDO Inhibitor 1
T35481204669-58-8
Epacadostat (INCB 024360) is an oral, potent and selective IDO1 inhibitor with IC50 value of 71.8 nM.
- 37 €
Size
QTY
CitedPalmatine Cited
Burasaine, Berbericinine
T5S08023486-67-7
1. Palmatine (Burasaine) is an inhibitor of dopamine generation. 2. Palmatine could potentially be developed for the treatment of flavivirus infections. 3. Palmatine has been used in the treatment of jaundice, dysentery, hypertension, inflammation, and liver-related diseases.
- 52 €
Size
QTY
CitedPalmatine chloride
T271810605-02-4
Palmatine chloride an isoquinoline alkaloid, is an important medicinal herbal extract with diverse pharmacological and biological properties.
- 37 €
Size
QTY
GNF-PF-3777
8-Nitrotryptanthrin
T1019977603-42-0
GNF-PF-3777 (8-Nitrotryptanthrin) is a potent inhibitor of human indoleamine 2,3-dioxygenase 2 (hIDO2) with a Ki of 0.97 μM.
- 28 €
Size
QTY
IDO-IN-7 Cited
NLG-919 analogue, NLG919, Navoximod, GDC-0919
T18061402836-58-1
IDO-IN-7 (NLG-919 analogue) is a potent inhibitor of the IDO (indoleamine-(2, 3)-dioxygenase) pathway.
- 36 €
Size
QTY
CitedNecrostatin-1 Cited
Necrostatin 1, Nec-1
T18474311-88-0
Necrostatin-1 (Nec-1) is a specific RIP1 inhibitor and necrotic apoptosis inhibitor, which inhibits TNF-α-induced necrotic apoptosis and also inhibits IDO.
- 28 €
Size
QTY
CitedCoptisine chloride
Q-100696, NSC-119754
T5S00566020-18-4
1. Coptisine chloride (NSC-119754) can be absorbed across intestinal epithelial cells, and completely absorbed compounds.
- 56 €
Size
QTY
IDO-IN-12
T116151888341-29-4In house
IDO-IN-12 is an inhibitor of indoleamine 2,3-dioxygenase (IDO).
- 76 €
Size
QTY
IDO5L
INCB14943, INCB024360 analogue
T2647914471-09-3
IDO5L (INCB024360 analogue) is an effective IDO1 inhibitor(IC50=10 nM).
- 40 €
Size
QTY
IDO inhibitor 1
T76601204669-37-3
IDO inhibitor 1 is an potent inhibitor of indoleamine-2,3 dioxygenase (IDO) ( IC50 <100 nM).with potential immunomodulating and antineoplastic activities.
- 86 €
Size
QTY
Coptisine sulfate
T4S00511198398-71-8
1. Coptisine sulfate has growth inhibitory activity against human cancer cell line in the NCI's anticancer drug screening program.
- 44 €
Size
QTY
Select Batch
Purity:99.08%
Contact us for more batch information
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.Product Introduction
Bioactivity
Chemical Properties
| Description | NLG802 is a prodrug of indoximod, serving as an orally active inhibitor of indoleamine 2,3-dioxygenase (IDO). |
| In vitro | NLG802 showed moderate direct (IC50 5 μM) and time dependent (7-fold shift) inhibition of CYP3A4, weak inhibition to CYP2D6 (IC50 19 μM) and CYP2C19 (IC50 47 μM), no inhibition of CYP450 1A2, 2B6, 2C8 and 2C9 (IC50 > 50 μM) and no induction of CYP1A2, 2B6 or 3A4 in human hepatocytes. NLG802 showed moderate inhibition of P-gp transporter activity in MDR1-MDCKII cells (IC50 27 μM), does not inhibit the anion and cation transporters OATP1B1, OATP1B3, OAT1, OAT3, OCT1 and OCT2 in HEK293 cells expressing these transporters (IC50 > 50 μM) or the BRCP transporter in Caco-2 cells[1]. |
| Molecular Weight | 395.92 |
| Formula | C20H30ClN3O3 |
| Cas No. | 2071683-99-1 |
| Smiles | Cl.CCOC(=O)[C@@H](Cc1cn(C)c2ccccc12)NC(=O)[C@@H](N)CC(C)C |
| Relative Density. | no data available |
Storage & Solubility Information
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 225 mg/mL (568.3 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . A total of 10 animals were administered, and the formula you used is 5% 
DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.Preparation method for in vivo formula: Take 50 μL DMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarify
main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarifyFor Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Keywords
Preview
Related Tags: buy NLG802 | purchase NLG802 | NLG802 cost | order NLG802 | NLG802 chemical structure | NLG802 in vitro | NLG802 formula | NLG802 molecular weight
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.